Cagrilintide/Semaglutide (5MG/5MG)

Description

CARG/Semaglutide is a composite peptide extensively studied for its combined potential effects on cellular pathways and metabolic regulation. This 5MG/5MG formulation is specifically designed for laboratory research in controlled experimental settings, offering researchers the opportunity to explore its properties and interactions.

The individual components of this product have been rigorously lab-tested to ensure quality and purity. The peptides are blended after separate testing, ensuring consistency and reliability for in vitro applications.

Cagrilintide: A long-acting amylin receptor agonist with potential implications in appetite, satiety, and energy regulation. Its structural optimization and extended half-life make it ideal for studies on obesity, appetite modulation, and metabolic hormone pathways.

Semaglutide: A synthetic peptide analog studied for its regulatory impact on glucose metabolism and weight-related biological functions. Frequently used in research focused on metabolic disorders and hormonal signaling mechanisms.

Note: This product is not intended for human or animal use. It is for laboratory research and in vitro testing only.